1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Defining Bath Ankylosing Spondylitis Disease Activity Index Cut-off Values for Disease Activity States in a Multinational European Cohort of Patients With Axial Spondyloarthritis
- Contribution to journal › Article
-
Mark
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased
- Contribution to journal › Article
-
Mark
Challenge of missing data in observational studies : investigating cross-sectional imputation methods for assessing disease activity in axial spondyloarthritis
- Contribution to journal › Article
-
Mark
Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study
- Contribution to journal › Article
-
Mark
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis
- Contribution to journal › Article
-
Mark
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis : results from nine European registries
- Contribution to journal › Article
-
Mark
Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
- Contribution to journal › Scientific review
-
Mark
Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors
- Contribution to journal › Article
- 2024
-
Mark
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis : results from nine European rheumatology registries
- Contribution to journal › Article
-
Mark
Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
- Contribution to journal › Article